Cadonilimab (AK104) With or Without CT as 2rd Line Treatment for ES-SCLC
Clinical trial NCT05901584 · UNKNOWN
Trial details
- NCT number
- NCT05901584
- Sponsor
- Second Affiliated Hospital of Zunyi Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-01
- Primary completion
- 2024-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.